JB Pharma rolls out its campaign #Heart2HeartChallengeIndia

The #Heart2HeartChallengeIndia campaign is very simple – you have to climb 60 steps in a minute, make a video of it, share it on your social media, tag 5 people, inviting them to take this challenge to check their heart health

India achieves significant landmark in reduction of child mortality rates

The country has been witnessing a progressive reduction in IMR, U5MR and NMR

KRSNAA leverages AI to deliver quality diagnostics to the rural hinterlands of India

Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune

Cipla receives EIR for Indore plant, Aurbindo for Raleigh

The plant at Raleigh, North Carolina, USA owned by Aurolife Pharma has received an establishment inspection report (EIR)

JB Pharma witness 20% growth in August 2022: IQVIA

Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.

Medical devices market in Singapore to reach $3.5 billion in 2022, forecasts GlobalData

Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments

DME market across 7MM set to reach $11.1 billion in 2031, forecasts GlobalData

Fujifilm India launches campaign to promote early diagnosis of TB

The campaign will also focus on providing doorstep TB screening services to facilitate diagnosis

Valent BioSciences promotes Salman Mir to EVP & COO

AstraZeneca likely to see substantial Evusheld uptake in Japan, says GlobalData

Japan’s Ministry of Health, Labour and Welfare (MHLW) has recently approved AstraZeneca's long-acting antibody combination “Evusheld” for the prevention ) and treatment of COVID-19.